BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29142359)

  • 1. Non-Hodgkin's Lymphoma with Pelvic Skeletal Muscle Involvement Presenting as Low Back Ache: An Uncommon Presentation of a Rather Common Malignancy.
    John AR; Gahlot GPS; Singh BK; Jain A; Mahato A; Jacob MJ
    Indian J Nucl Med; 2017; 32(4):355-358. PubMed ID: 29142359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promising Role of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Human Immunodeficiency Virus Associated Non-Hodgkin's Lymphoma.
    Kung BT; Mak WS; Lau SM; Auyong TK; Tong CM
    World J Nucl Med; 2015; 14(1):53-6. PubMed ID: 25709547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse skeletal muscle F-18 fluorodeoxyglucose uptake in advanced primary muscle non-Hodgkin's lymphoma.
    Broski SM; Bou-Assaly W; Gross MD; Fig LM
    Clin Nucl Med; 2009 Apr; 34(4):251-3. PubMed ID: 19300063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactate dehydrogenase levels and 18F-FDG PET/CT metrics differentiate between mediastinal Hodgkin's lymphoma and primary mediastinal B-cell lymphoma.
    Alkhawtani RHM; Noordzij W; Glaudemans AWJM; van Rijn RS; van der Galiën HT; Balink H; Nijland M; Adams HJA; Huls G; van Meerten T; Kwee TC
    Nucl Med Commun; 2018 Jun; 39(6):572-578. PubMed ID: 29672465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Rare Case of Primary Uterine Non-Hodgkins's Lymphoma with Involvement of Right Ovary: Staging with 18F FDG PET/CT and Iodinated Contrast CT.
    Lamacchia F; Cimini A; Ferrari D; Chiaravalloti A; Schillaci O; Floris R
    Indian J Nucl Med; 2019; 34(1):60-61. PubMed ID: 30713385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive Extranodal Involvement of Rare Sites in Non Hodgkin's Lymphoma Detected on (18)F- FDG PET-CT: A Case Report.
    Dhull VS; Sharma P; Singla S; Faizi NA; Thulkar S; Bal C; Kumar R
    Nucl Med Mol Imaging; 2013 Jun; 47(2):125-9. PubMed ID: 24900093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-Hodgkin's lymphoma of the testicle and bilateral adrenals detected by (18)F-FDG PET/CT.
    Yin Y; Qing F; Li X; DU B; Li N; Li Y
    Exp Ther Med; 2011 Sep; 2(5):817-820. PubMed ID: 22977581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [18F]Fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin's lymphoma.
    Purz S; Mauz-Körholz C; Körholz D; Hasenclever D; Krausse A; Sorge I; Ruschke K; Stiefel M; Amthauer H; Schober O; Kranert WT; Weber WA; Haberkorn U; Hundsdörfer P; Ehlert K; Becker M; Rössler J; Kulozik AE; Sabri O; Kluge R
    J Clin Oncol; 2011 Sep; 29(26):3523-8. PubMed ID: 21825262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory Myalgia, A Rare Presentation of Hodgkin's Lymphoma: About a Case.
    Chergaoui I; Kherrab A; Ghazi M; Raissi A; Azami MA; Niamane R
    Cureus; 2023 Oct; 15(10):e47379. PubMed ID: 38021870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incidence of secondary central nervous system involvement in patients with non-Hodgkin's lymphoma as detected by 18F-FDG PET/CT.
    Akkas BE; Vural GU
    Nucl Med Commun; 2013 Jan; 34(1):50-6. PubMed ID: 23111376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy.
    Teagle AR; Barton H; Charles-Edwards E; Dizdarevic S; Chevassut T
    Acta Radiol; 2017 Dec; 58(12):1476-1484. PubMed ID: 28382828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of 18F-FDG PET/CT as a staging tool in patients with newly diagnosed lymphoma.
    Cho SF; Chang CC; Liu YC; Chang CS; Hsiao HH; Liu TC; Huang CT; Lin SF
    Kaohsiung J Med Sci; 2015 Mar; 31(3):130-7. PubMed ID: 25744235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of 18F-FDG PET and 18F-FDG PET/CT in the evaluation of pediatric Hodgkin's lymphoma and non-Hodgkin's lymphoma.
    Qiu L; Chen Y; Wu J
    Hell J Nucl Med; 2013; 16(3):230-6. PubMed ID: 24137577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High SUV uptake on FDG-PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET/CT staging in lymphoma.
    Ngeow JYY; Quek RHH; Ng DCE; Hee SW; Tao M; Lim LC; Tan YH; Lim ST
    Ann Oncol; 2009 Sep; 20(9):1543-1547. PubMed ID: 19474116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Hodgkin's lymphoma presenting as a primary bladder tumor: a case report.
    Díaz-Peromingo JA; Tato-Rodríguez J; Pesqueira-Fontán PM; Molinos-Castro S; Gayol-Fernández MC; Struzik JP
    J Med Case Rep; 2010 Apr; 4():114. PubMed ID: 20420660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kimura Disease Simulating Hodgkin's Lymphoma on (18)F FDG PET-CT: Report of a Case.
    Yang TH; Chou YH; Kao WY; Cherng SC
    Nucl Med Mol Imaging; 2014 Dec; 48(4):313-6. PubMed ID: 26396638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurolymphomatosis - Rare presentation in non-Hodgkin's lymphoma: The role of
    Fatima N; Zaman MU; Zaman A; Zaman SU
    World J Nucl Med; 2020; 19(2):159-161. PubMed ID: 32939208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staging and monitoring response to treatment in primary non-Hodgkin's lymphoma of bone marrow using (18)F-fluorodeoxyglucose positron emission tomography.
    Matthies A; Schuster SJ; Alavi A
    Clin Lymphoma; 2001 Mar; 1(4):303-6; discussion 307. PubMed ID: 11707846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma.
    Wirth A; Seymour JF; Hicks RJ; Ware R; Fisher R; Prince M; MacManus MP; Ryan G; Januszewicz H; Wolf M
    Am J Med; 2002 Mar; 112(4):262-8. PubMed ID: 11893364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computed tomography and 18F-FDG positron emission tomography for therapy control of Hodgkin's and non-Hodgkin's lymphoma patients: when do we really need FDG-PET?
    Reinhardt MJ; Herkel C; Altehoefer C; Finke J; Moser E
    Ann Oncol; 2005 Sep; 16(9):1524-9. PubMed ID: 15946979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.